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AB! H W C T  
In the tropics, hepatitis C virus (HCV) seroprevalence ranges from 4 .2% in whole Africa 
Mother-to-infant transmission of HCV though relatively low, have been reported worldwide and 
transmission may be intrauterine, intrapartum and post-natal. A descriptive seroepidemiologic study of 
hepatitis C virus and their associated risk factors have been conducted among pairs of mother and child 
of  pre-~cRoo1 age attending the "well child" clinic of the University of Ilorirr, Teaching Hospital and the 
in;nsun'lzation clinic of the children specialist hospital, Ilorin. Sera of 70% mother1chPd pdrs were 
su!.;+.ted to Enzyme-Linked Immunoabsorbent Assay (ELISA) fcr the detection oP antr'bwjies clirected 
against the core and structural proteins of hepatitis C \ins (anti-ACV). 
Anti-HCV prevaience of 1.4% was seen among mothers while none of the children was ;rositive 
for inti-HCV. Scarification appeared to be the rnwt s i g n i r i t  risk factors tbat could mssibly 
contribute to the transmission of HCV among the subjects. The o d y  motbcr positive for anti-HCV 
antibodies had tribal mark scarification while her $year old baby wlro h d  w tribal mark wrrr negative. 
Vaccination has been effective in reducing the incidence of heprtItis B and attending 
complications of onset of hepatocellular carcinoma later in life; but preventive measares against hepatitis 
C virus are not yet available 
INTRODUCTION hepatitis in up to 80% of individuals. This is the 
Over the past decade, hepatitis C virus highest rate of chronicity of the hepatotrophic 
(HCL') infection has risen 6om an obscure disease 
into a publK hu.M p-okdem all around the world. 
At present, there an m ezmmd 170 mill~on HCV 
carriers wddwide rnos of atrm arc thought to be 
- the developing c o m t r k  (!). hi &K HBV 
-=- A -,.ion, HCV infection may be -d 
n - d l y  by transfusion of b l d  ad SJod 
r-venous - drug abase and 
rnjectims. However, in 40-45% of HCL' 
ln fd~ons ,  no obvious parenteral exposure have 
been identified (2). The acute HCV inf&on is 
commonly asymptomatic but. leads to chronic 
viruses occurring in adults and is striking when 
compared to HBV infections that becomes chronic 
in only 5% to 10% of infections occumng in 
adulthood (3). 
Vertically transmitted infection becomes 
chronic in the majority of w a t r i c  cases, as in 
adult cases. The ultimate outcome of neonatal 
infection remains largely unhown because of the 
lack of data from long term longitudinal studies of 
infeirted children (4). Mother-to-child transmission 
rate of hepatitis C virus (HCV) is low, less man 
iO% in women not cczinfected with HIV. ]Due: to 
the fact that most published studies have included a 
small number of HCV-RNA positive children 
(n<lO), the transmission risk factors remain still 
unclear. lnvasive procedures, such as 
aminocentesis or use of forceps, could increase thc 
risk of transmission (5). In Nigeria, where hepatitis 
B virus infection is hyperendemic, the impact of 
chronic hepatitis C virus infection has not been 
adequately elucidated most especially in  mothers 
and their pre-school age children. This study was 
therefore aimed at finding the seroprevalence of 
HCV and their associated risk facton among pairs 
of mother and child of pre-school age anending the 
".veil child" clinic of the University of I!mn 
Teaching Hospital and the immunkuion clinic of 
the Children Specialist Hospital, Ilorin. 
MATERIALS AND METHODS 
Subjects 
Seventy (70) pre-school a s  c'dldren 
attending the "WELL CHILD- Clinic in the 
University of Ilon'n Teaching H o w l  and the 
Children Specialist Hospital (Center lgboro) in 
llorin and their mothers were randomly recruited 
for this study. Children attending these clln~cs in 
the company of other relatives and those above five 
years of age were exempted from this study. 
Subjects were verbally informed of the 
study. A questionnaire was used to obtain personal 
data such as age and possible modes of 
iransmission of HCV or risk factors such as history 
of previous blood transfusion, history of 
circumcision, history of jaundice, history of use of 
unsterile needles, history of HBV vaccination and 
history of scarification (Tribal marks). 
Serum samples were cbtained from 
mothers and also from their children by 
vaqmmm and stored frozen in aliquots at - 
20°C. Anti-HCV was detected usine third 
generation enzyme linked imrnunoabsorbent assay 
(ELISA) kit (Ortho diagostics Raritan. New 
Jersey USA). A repeat ELISA test was performed 
on each positive anti-HCV sample, in order to 
eliminate false positivity. Results were regarded as 
positive after a repeat pos~tive ELlSA test. 
The results were subjected to statistical 
analysis using EPI-Info Version 6 Software 
package. Bar Chart and Cross tabulation tables 
were done. The critical level for statistical 
significance was set at 5% confidence level using 
the chi-square analysis. 
RESULTS 
The age distribution of children whose mothers 
participated in this study is shown in figure 1. Of 
the 70 respondents about 4.3% of the children are 
within the age of less than 1, 24.3% within the age 
of I .  3 1 .doh within the age 2, 21.4% within the age 
3. 15.7% within age 4 and 2.9% w i t h - a g e  5. Of 
the respondents, 1 (1.43%) mother was positive for 
anti-HCV antibodies while 69 (98.57%) was 
negixtive. It is interesting to note in this study that 
none (P!) of the children was positive for anti- 
HCV antibodies (Table 1). The possible modes of 
transmission of risk factors and prevalence rates are 
shown in Tables 2 and 3. In the case of the only 
mother positive for anti-HCV antibodies, results 
indicated that the history of circumcision; history 
of scarification (tribal marks) and history of . . 
previous use of unsterile needles were the 
associated risk factors linked with her anti-HCV 
antibodies positivity (Table 2). This finding 
statistically were significant with P values of 
0.04 1 1,0.0163 and 0.0425 respective1 y (Table 3). 
However, no significant association 
statistically were found between HCV 
Seropositivity in the only positive mother with 
history of previous blood iransfusion, history of 
jaundice and history of HBV vaccination [P values 
of 0.758,0.758 and 0.7!7 respectively] (Table 3). 
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Figure 1 .  Age distribution of childrcn of n~othcrs u s c ~  I:) I I I I S  study. 
This bar chart sliows thc agc distr~hutio~l or childrcn whosc mothcr participated in this study. About 4.3% of the 
children are within the age of lcss than 1 .  24.3"" ul:hln thc age of I .  31.4% within the age 2, 21.4% within age 3, 15.7% 
within age 4 and 2.9% within agc 5. 
Table 1 Prevalence of antibodies to HC\. (anti-ll< \ I  i n  relation to mother and child. 
-- - 
HCV Ah Mother Child 
Posl tive i (1 .43%) 0 t P * )  
Ncgative (I!, (98.57%) 70 (100.0) 
Total 70 ( 1 00%) 70 (10O0b) 
Table  2 Description of the various modes of H C V  transmission and  prevalence ra tes  in mothers .  
31ode anti-HCV Positive (n  = I )  Percentage h/o 
Hist.ory o i p r c \ ~ w s  b ' a e  :ransfusion 0 0 
History of CI~CLITK~STF 1 
100 
History of Jaundice 0 
0 
Y~story of  HBV vaccination 0 
0 
of Tribal Marks (Scarificatim 
:-'.nary of Usc of tlnsterile hecdles 
*where n is the total number anti-HCV posi t~vs  rno!hers 
Table 3 Risk factors, confidence intervals and P values in relation to mothers HCV transmission 
Risk Factor Chi-square 5% C.1 & P values Comments 
History of blood transfusion 
History of Circumcision 
History of Jaundice 
History of HBV vaccination 
History of Tri bal Marks 
(Scarification) 
Hinosy of use of unsterile 
needles 
* C.I. means confidence intcrval. 
P = 0.758 P > 0.05 
There is no statistically 
P=O.0411 significant difference 
P < 0.05 
P = 0.758 There is statisticaily significant 
difference 
P = 0.717 P > 0.05 
There is no statistically 
P = 0.0163 significant difference 
P > 0.05 
P = 0.0425 There is no statistically 
significant difference 
P < 0.05 
There is statistically significant 
difference 
P < 0.05 
There is statistically significant 
difference 
DISCUSSION 
Hepatitis C virus (HCV) belongs to the 
Flavi family and it is a RNA virus with prcvalence 
rate in most countries of less than three (3) percent 
(6). Hepatitis C virus plays an important role in the 
causation of hepatocellular carcinoma (7). In this 
study, ages of children screened for hepatitis C falls 
between less than 1 and 5 years with children 
within age 2 having the highest percentage of 
31.4% and children of age 5 having the lowest 
percentage of 2.9% (Figure 1). This age group is in 
consonance with the work done by (8) whose study 
determined the age wise prevalence of Hepatitis C 
virus in children under five years and analysed the 
relative importance of horizontal or vertical 
transmission. 
In this study, of all the children screened 
for HCV anti-bodies, none was positive for anti- 
HCV. However, only 1 mother was found positive 
for anti-HCV (Table 1). It is interesting to note 
that of all the risk factors for the transmission of 
HCV infection investigated in this study, the only 
positive mother had history of circumcision, tribal 
mark and history of usage of unsterile needle for 
injection in the past (Tables 2 and 3). This result 
revealcd that the prevalence of hepatitis C infection 
in this environment is low. This finding is at 
variance with the result in the work done by (9) 
who reported 5% prevalence of antibodies to 
hepatitis C virus among normal blood donors and 
multi-transfused sickle-cell anaemia patients in the 
same environment. 
The plausible reason for this differences 
could be in the sensitivity of the kits used in both 
studies. In this study. the third generation ELISA 
kit was used as again3 the second generation 
ELlSA kits used in the work done by (9). 
Intravenous drug abuse. haemophila and 
homosexuality have been identified as high risk 
factors for hepatitis C virus transmission (10). 
These same risk factors have been associated with 
HBV infection. Furthermore, it has been reported 
that rates of transmission varied from one study to 
another probably because the risk of transmission 
varies in different population of women studied. 
Socio-a~ltural factors such as tribal markings by 
. 
scarification and female genital circumcision are 
not common in the part of the world except in some 
African societies. These socio-cultural practices 
are often done by the use of scientifically 
unsterilized devices. It is plausible to suggest that 
engagement in these activities as verified in the 
singular case that was positive for HCV antibodies 
could have exposed this person to infection with 
Hepatitis C virus. 
In summary, prevention remains the key 
for HCV transmissions. Older children and mothers 
require education about high-risk behaviours. 
Prevention of perinatal transmission should also be 
targeted. HCV infection occurs in children and is 
frequently less severe or more prolonged. Children 
might have a better response rate to therapy, but 
this is based upon very small and uncontrolled 
studies. Education is important to prevent 
transmission of HCV infection to adolescents and 
newborn (I 1). 
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